Polymorphism of genes localized on the X-chromosome as a marker of predisposition to infectious process chronicity at hepatitis C in the ethnic group of male Yakuts
https://doi.org/10.25789/YMJ.2019.66.19
Abstract
The work studied variable sites of six genes localized on the X-chromosome in the Yakut ethnic group. The candidate TLR7 rs179009 gene was found, the C-allele of which is associated with the chronic course of hepatitis C. The minor C allele is more than 2 times more common in patients with chronic hepatitis C than in the group with spontaneous recovery. It was found that the chances of hepatitis transition to a chronic course is 2.7 times higher in carriers of the C-allele than in carriers of the T-allele rs179009 TLR7. The obtained data confirm the possible significance of the rs179009 polymorphism of the TLR7 gene as a genetic marker of predisposition to the chronicity of the infectious process while viral hepatitis C in the ethnic group of male Yakuts.
Keywords
About the Authors
S. S. SleptsovaRussian Federation
Sleptsova Snezhana Spiridonovna - Doctor of Medical Sciences, Associate Professor, Head of the Department of Infectious Diseases, Phthisiology and Dermatovenereology of the Medical Institute, tel. 8-914-2718770
677010, Yakutsk, ul. Oiunsky, 27
I. F. Bilyukina
Russian Federation
Bilyukina Iraida Fedoseyevna - full-time graduate student of the Department of Infectious Diseases, Phthisiology and Dermatovenereology of the Medical Institute, tel. 8-962- 7321207
677010, Yakutsk, ul. Oyunskogo, 27
S. I. Malov
Russian Federation
Malov Sergey Igorevich, PhD, Assistant Professor, Department of Infectious Diseases
Irkutsk
S. I. Semenov
Russian Federation
Semenov Sergey Innokentievich - doctor of medical sciences, leading researcher of SIC, tel. 8-914-2862948
L. A. Stepanenko
Russian Federation
Stepanenko Liliya Alexandrovna - PhD, Senior Lecturer Research Institute of Biomedical Technologies,
Irkutsk
O. B. Ogarkov
Russian Federation
Ogarkov Oleg Borisovich - Ph.D. Department of Epidemiology and Microbiology
Irkutsk
E. D. Savilov
Russian Federation
Savilov Evgeniy Dmitrievich - doctor of medical sciences, professor, chief researcher of the department of epidemiology and microbiology
Irkutsk
I. V. Malov
Russian Federation
Malov Igor Vladimirovich - Doctor of Medical Sciences, Professor, Head of the Department of Infectious Diseases
Irkutsk
References
1. Peculiarities of the III type interferon genes’ polymorphism in HCV patients on the cross-border regions of Russia and Mongolia / I.V. Malov, O. Baatarkhuu, O.B. Ogarkov [et al.] // Journal Infectology. -2017. -№9(3). -P.46-53. doi: 10.22625/2072-6732-2017-9-3-46-53
2. Pimenov N.N. Modern epidemiological characteristics of chronic hepatitis C and its outcomes in the Russian Federation / N.N. Pimenov, V.P. Chulanov // Proceedings of the IX All-Russian Scientific and Practical Conference of Young Scientists and Specialists of Rospotrebnadzor. - Irkutsk, 2017.
3. Simbirtsev A.S. Cytokines in the pathogenesis of infectious and noninfectious human diseases / A.S. Simbirtsev// Medical academic journal. -2013. №13(3). – P.18-41.
4. Sleptsova S.S. Parenteral viral hepatitis and their origin in the Republic of Sakha (Yakutia) – / S.S. Slepsova. -M., 2017. -216 p.
5. Epidemiology of hepatitis C in the Moscow Region: data from the Moscow Regional Registry and screening for HCV antibodies / P.O. Bogomolov, A.O. Bueverov, M.V. Matsievich [et al.] // Almanac of Clinical Medicine. -2016. -№44(6). –P.689–696. doi: 10.18786/2072-0505-2016-44-6-689-696.
6. Akaike H. A new look at the statistical model identification / H. Akaike// IEEE Transactions on Automatic Control. 1974; 19(6): 716-723.
7. Askar E. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection / E. Askar, G. Ramadori, S. Mihm // J Med Virol. 2010; 82(11): 1859-1868. doi: 10.1002/jmv.21893.
8. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV /Y.M. Mosaad, S.S. Metwally, R.E. Farag [et al.] // Immunol Invest. 2018; 15: 1-12. doi: 10.1080/08820139.2018.1527851. [Epub ahead of print]
9. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection / M.R. Al-Anazi, S. Matou-Nasri, A.A. Abdo [et al.] // J Immunol Res. 2017; 2017: 1590653. doi: 10.1155/2017/1590653.
10. Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection- Differential influenceinindividualswithdistinctethnicbackground / J.M. Valverde-Villegas, B.P. Dos Santos, R.M. de Medeiros [et al.] // Hum Immunol. 2017; 78(2): 221-226. doi: 10.1016/j.humimm.2017.01.001.
11. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel / Y. Maor, G. Morali, D. Bashari [et al.] // Haemophilia. 2013; 19(1): 150-156. doi: 10.1111/j.1365-2516.2012.02932.x.
12. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus / D.L. Thomas, C.L. Thio, M.P. Martin [et al.] // Nature. 2009; 461(7265): 798-801. doi: 10.1038/nature08463.
13. Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression / F.Z. Fakhir, M. Lkhider, W. Badre [et al.] // Liver Int. 2018; 38(3): 432-442. doi: 10.1111/liv.13533.
14. Hierarchical assessment of host factors influencing the spontaneous resolution of hepatitis C infection / P.J.S. Provazzi, L.M.G. Rossi, B.M. Carneiro [et al.] // Braz J Microbiol. 2018. doi: 10.1007/s42770-018-0008-3. [Epub ahead of print]
15. Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferonsignaling pathway / Y. Liang, X. Cao, Q. Ding [et al.] // PLoS Pathog. 2018; 14(5): e1007075. doi: 10.1371/journal.ppat.1007075.
16. Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care / L.I. Backus, P.S. Belperio, T.P. Loomis, L.A. Mole // Am J Public Health. 2014; 104 Suppl 4: S555-561. doi: 10.2105/AJPH.2014.302090.
17. Impaired Toll-Like Receptor 3-Mediated Immune Responses from Macrophages of Patients Chronically Infected with Hepatitis C Virus / F. Qian, C.R. Bolen, C. Jing [et al.] // Clin Vaccine Immunol. 2013; 20(2): 146-155. doi: 10.1128/CVI.00530-12.
18. Kawasaki T. Toll-like receptor signaling pathways / T. Kawasaki, T. Kawai // Front Immunol. 2014; 5: 461. doi: 10.3389/fimmu.2014.00461
19. Maglione P.J. Toll-like receptor signaling in primary immune deficiencies / P.J. Maglione, N. Simchoni, C. Cunningham-Rundles // Ann N Y Acad Sci. 2015; 1356: 1-21. doi: 10.1111/nyas.12763.
20. Mittal S. Epidemiology of hepatocellular carcinoma: consider the population / S. Mittal, H.B. El-Serag // J Clin Gastroenterol. 2013; 47 Suppl: S2-6. doi: 10.1097/MCG.0b013e3182872f29.
21. Mizokami M. Discovery of critical host factor, IL-28B, associated with response to hepatitis C virus treatment / M. Mizokami // J. Gastroenterol. Hepatol. 2012; 27(3): 425-429. doi: 10.1111/j.1440-1746.2011.07054.x.
22. Natural history of hepatitis C in thalassemia major: a long-term prospective study / M.E. Lai, R. Origa, F. Danjou [et al.] // Eur. J. Haematol. 2013; 90(6): 501-507. doi: 10.1111/ejh.12086
23. Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population / J. Fischer, E. Koukoulioti, E. Schott [et al.] // Sci Rep. 2018; 8(1): 12737. doi: 10.1038/s41598-018-31065-6.
24. Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection / A. Svensson, P. Tunbäck, I. Nordström [et al.] // J Gen Virol. 2012; 93(Pt8): 1717-1724. doi: 10.1099/vir.0.042572-0.
25. The DNA sequence of the human X chromosome / M.T. Ross, D.V. Grafham, A.J. Coffey [et al.] // Nature. 2005; 434(7031): 325-337.
Review
For citations:
Sleptsova S.S., Bilyukina I.F., Malov S.I., Semenov S.I., Stepanenko L.A., Ogarkov O.B., Savilov E.D., Malov I.V. Polymorphism of genes localized on the X-chromosome as a marker of predisposition to infectious process chronicity at hepatitis C in the ethnic group of male Yakuts. Yakut Medical Journal. 2019;(2):64-67. https://doi.org/10.25789/YMJ.2019.66.19